  | SCHOENEN, J., Timmermans, G., Nonis, R., MANISE, M., FUMAL, A., & GERARD, P. (2021). Erenumab for Migraine Prevention in a 1-Year Compassionate Use Program: Efficacy, Tolerability, and Differences Between Clinical Phenotypes. Frontiers in Neurology, 12, 805334. doi:10.3389/fneur.2021.805334  Peer Reviewed verified by ORBi |
 | SCHOENEN, J., MANISE, M., Nonis, R., GERARD, P., & Timmermans, G. (December 2020). Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention. Revue Neurologique, 176 (10), 788-803. doi:10.1016/j.neurol.2020.04.027 Peer Reviewed verified by ORBi |
  | Lisicki, M., Carpinella, M., Coppola, G., Zamparella, T. C., Ruiz-Romagnoli, E., MANISE, M., de Noordhout, A. M., SCHOENEN, J., & Magris, D. C. (2020). In silico analysis of gene expression in V3a and the superior occipital gyrus: Relevance for migraine. Cephalalgia Reports, 3, 251581632096440. doi:10.1177/2515816320964405 Peer Reviewed verified by ORBi |
 | Manise, M., Bakayoko, B., SCHLEICH, F., Corhay, J.-L., & Louis, R. (July 2016). IgE mediated sensitisation to aeroallergens in an asthmatic cohort: relationship with inflammatory phenotypes and disease severity. International Journal of Clinical Practice, 70 (7), 596-605. doi:10.1111/ijcp.12837 Peer Reviewed verified by ORBi |
 | Nguyen, M.-S., NGUYEN DANG, D., SCHLEICH, F., Manise, M., CORHAY, J.-L., & LOUIS, R. (2015). Etude du phénotype mixte BPCO-asthme dans une série de patients BPCO en état stable. Revue Médicale de Liège, 70 (1), 37-43. Peer reviewed |
 | SCHLEICH, F., Brusselle, G., Louis, R., Vandenplas, O., Michils, A., Pilette, C., Peche, R., Manise, M., & Joos, G. (December 2014). Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR). Respiratory Medicine, 108 (12), 1723-32. doi:10.1016/j.rmed.2014.10.007 Peer Reviewed verified by ORBi |
 | SCHLEICH, F., Chevremont, A., PAULUS, V., HENKET, M., Manise, M., Seidel, L., & Louis, R. (2014). Importance of concomitant local and systemic eosinophilia in uncontrolled asthma. European Respiratory Journal, 44, 97-108. doi:10.1183/09031936.00201813 Peer Reviewed verified by ORBi |
 | SCHLEICH, F., Manise, M., Sele, J., HENKET, M., Seidel, L., & LOUIS, R. (2013). Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation. BMC Pulmonary Medicine, 13 (1), 11. doi:10.1186/1471-2466-13-11 Peer Reviewed verified by ORBi |
 | Manise, M., Holtappels, G., Van Crombruggen, K., SCHLEICH, F., Bachert, C., & LOUIS, R. (2013). Sputum IgE and Cytokines in Asthma: Relationship with Sputum Cellular Profile. PLoS ONE, 8 (3), 58388. doi:10.1371/journal.pone.0058388 Peer Reviewed verified by ORBi |
 | Kuipers, I., LOUIS, R., Manise, M., Dentener, M. A., Irvin, C. G., Janssen-Heininger, Y. M. W., Brightling, C. E., Wouters, E. F. M., & Reynaert, N. L. (2013). Increased glutaredoxin-1 and decreased protein S-glutathionylation in sputum of asthmatics. European Respiratory Journal, 41 (2), 469-72. doi:10.1183/09031936.00115212 Peer Reviewed verified by ORBi |
Manise, M. (2012). Immuno-inflammatory mechanisms in refractory asthma [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/143413 |
SCHLEICH, F., ASANDEI, R., Manise, M., SELE, J., Seidel, L., & LOUIS, R. (2012). Is FE(NO50) useful diagnostic tool in suspected asthma? International Journal of Clinical Practice, 66 (2), 158-65. doi:10.1111/j.1742-1241.2011.02840.x Peer Reviewed verified by ORBi |
 | MANISE, M., SCHLEICH, F., QUAEDVLIEG, V., Moermans, C., HENKET, M., SELE, J., CORHAY, J.-L., & LOUIS, R. (2012). Disturbed Cytokine Production at the Systemic Level in Difficult-to-Control Atopic Asthma: Evidence for Raised Interleukin-4 and Decreased Interferon-gamma Release following Lipopolysaccharide Stimulation. International Archives of Allergy and Immunology, 158 (1), 1-8. doi:10.1159/000329858 Peer Reviewed verified by ORBi |
 | Moermans, C., HEINEN, V., NGUYEN DANG, D., HENKET, M., SELE, J., Manise, M., Corhay, J.-L., & Louis, R. (2011). Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease. Cytokine, 56 (2), 298-304. doi:10.1016/j.cyto.2011.07.010 Peer Reviewed verified by ORBi |
 | Manise, M., Schleich, F., Gusbin, N., Godinas, L., Henket, M., Antoine, N., Corhay, J.-L., & Louis, R. (2010). Cytokine production from sputum cells and blood leukocytes in asthmatics according to disease severity. Allergy, 65 (7), 889-96. doi:10.1111/j.1398-9995.2009.02296.x Peer Reviewed verified by ORBi |
 | Louis, R., Manise, M., Sele, J., & Schleich, F. (2010). Inertie et observance therapeutiques en tant que facteurs influencant le controle de l'asthme. Revue Médicale de Liège, 65 (5-6), 338-42. Peer reviewed |
 | Schleich, F., Seidel, L., Sele, J., Manise, M., Quaedvlieg, V., Michils, A., & Louis, R. (2010). Exhaled nitric oxide thresholds associated with a sputum eosinophil count >=3% in a cohort of unselected patients with asthma. Thorax, 65 (12), 1039-1044. doi:10.1136/thx.2009.124925 Peer Reviewed verified by ORBi |
 | Schleich, F., Manise, M., & Louis, R. (2009). L'omalizumab (Xolair) dans le traitement de l'asthme allergique persistant severe. Revue Médicale de Liège, 64 (5-6), 313-7. Peer reviewed |
 | Manise, M., & Louis, R. (2008). Asthme réfractaire : mécanismes sous-jacents, diagnostics et nouvelles approches thérapeutiques. Revue Médicale de Liège, 63 (7-8), 494-499. Peer reviewed |